Patel Sandip I

DirectorPeak Bio, Inc. (PKBO) · full profile →Form 4 · filed Nov 18, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
5 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 14, 2024Conversion(C)763K763K
Nov 14, 2024Disposed to issuer(D)69K0
Nov 14, 2024Disposed to issuer(D)68K0
Nov 14, 2024Disposed to issuer(D)47K0
Nov 14, 2024Disposed to issuer(D)763K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 14, 2024Disposed to issuer(D)0$00
Nov 14, 2024Conversion(C)400K0

Transaction Codes

C
Conversion of a derivative
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-128153) within minutes of acceptance. Every field above traces to the original document. Verify it directly: